Breaking News Instant updates and real-time market news.

ENZ

Enzo Biochem

$5.04

-0.055 (-1.08%)

16:07
10/13/16
10/13
16:07
10/13/16
16:07

Enzo Biochem reports Q4 adjusted EPS (4c), one estimate (6c)

Reports Q4 revenue $26.6M, one estimate $26M. "Fiscal 2016 was a highly successful year for Enzo Biochem," said Enzo president Barry Weiner. "We solidified our growth opportunities on every front, setting a strong foundation for the future. Life Sciences' product development emphasis on high profit margin products is paying off with several key approvals awarded in 2016. Enzo Labs came off a strong year with solid forward momentum from its expanding line of innovative molecular diagnostics, especially in the women's health category, and a growing client roster. The unique combination of our Life Sciences development and marketing team with our Clinical Labs' hands-on testing capabilities, and our deep patent estate, has resulted in a formidable development program, to prepare our broad pipeline of products for regulatory approval."

  • 14

    Oct

TODAY'S FREE FLY STORIES

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.